Skip to main content

Advertisement

SpringerLink
Log in

The Bidirectional Relation Between Psychiatric Disorders With Selected Cardiovascular and Endocrinal Diseases: An Egyptian Perspective

  • Complex Medical-Psychiatric Issues (MB Riba, Section Editor)
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Cardiovascular and endocrine diseases may act as burdens for individuals suffering from one of these medical illnesses, and whether through the ensuing psychological distress, or some biological mechanisms, these medical diseases can eventually lead to the development of psychiatric morbidities. Moreover, psychiatric morbidities negatively affect the prognosis of both cardiovascular and endocrine diseases. Despite transcultural differences, Egyptian patients with ischemic heart diseases (ISHD), heart failure (HF), diabetes mellitus (DM), or thyroid diseases (TD) endure the same psychological distress as their Western counterparts. Psychiatric assessment and evaluation should be regularly repeated among patients with cardiovascular and endocrinal diseases, and patients who are at risk should be closely followed up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Turner J, Kelly B. Emotional dimensions of chronic disease. West J Med. 2000;172(2):124–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Cully JA, Johnson M, Moffett ML, Khan M, Deswal A. Depression and anxiety in ambulatory patients with heart failure. Psychosomatics. 2009;50(6):592–8.

    PubMed  Google Scholar 

  3. Sarkar S, Chadda RK, Kumar N, Narang R. Anxiety and depression in patients with myocardial infarction: findings from a centre in India. Gen Hosp Psychiatry. 2012;34(2):160–6.

    PubMed  Google Scholar 

  4. Van Melle JP, de Jonge P, Kuyper AM, et al. Prediction of depressive disorder following myocardial infarction data from the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Int J Cardiol. 2006;109(1):88–94.

    PubMed  Google Scholar 

  5. Moser DK, Dracup K, Evangelista LS, et al. Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung. 2010;39(5):378–85.

    PubMed Central  PubMed  Google Scholar 

  6. Guallar-Castillón P, Magariños-Losada MM, Montoto-Otero C, et al. Prevalence of depression and associated medical and psychosocial factors in elderly hospitalized patients with heart failure in Spain. Rev Esp Cardiol. 2006;59(8):770–8.

    PubMed  Google Scholar 

  7. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65(1):62–71.

    CAS  PubMed  Google Scholar 

  8. de Jong MJ, Chung ML, Wu JR, Riegel B, Rayens MK, Moser DK. Linkages between anxiety and outcomes in heart failure. Heart Lung. 2011;40(5):393–404.

    PubMed Central  PubMed  Google Scholar 

  9. Delisle VC, Arthurs E, Abbey SE, et al. Symptom reporting on the Beck Depression Inventory among post-myocardial infarction patients: in-hospital versus follow-up assessments. J Psychosom Res. 2012;73(5):356–61. This study highlighted the persistent course of depression in patients with heart failure, emphasizing that it was more than a mere reaction.

    PubMed  Google Scholar 

  10. Diez-Quevedo C, Lupón J, González B, et al. Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol. 2013;167(4):1217–25.

    PubMed  Google Scholar 

  11. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66(6):814–22.

    PubMed  Google Scholar 

  12. Huffman JC, Smith FA, Blais MA, Januzzi JL, Fricchione GL. Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction. J Psychosom Res. 2008;65(6):557–63.

    PubMed  Google Scholar 

  13. Roest AM, Martens EJ, De Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;56(1):38–46.

    PubMed  Google Scholar 

  14. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527–37.

    PubMed  Google Scholar 

  15. Roriz Dias M, Koike MK. Pathogenesis of depression after myocardial infarction: rationale, state of the art and perspectives. Prog Health Sci. 2013;3(1):123–7.

    Google Scholar 

  16. Wirtz PH, Redwine LS, Linke S, Hong S, Rutledge T, Greenberg BH, et al. Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients. Brain Behav Immun. 2010;24(3):366–9.

    CAS  PubMed  Google Scholar 

  17. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. Eur Heart J. 2008;29(18):2212–7.

    CAS  PubMed  Google Scholar 

  18. Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54(3):248–61.

    PubMed  Google Scholar 

  19. Merswolken M, Deter HC, Siebenhuener S, Orth-Gomér K, Weber CS. Anxiety as predictor of the cortisol awakening response in patients with coronary heart disease. Int J Behav Med. 2013;20(3):461–7.

    PubMed  Google Scholar 

  20. Mazereeuw G, Herrmann N, Bennett SA, et al. Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. Neurosci Biobehav Rev. 2013;37(8):1611–21.

    CAS  PubMed  Google Scholar 

  21. Dimos AK, Stougiannos PN, Kakkavas AT, Trikas AG. Depression and heart failure. Hell J Cardiol. 2009;50(5):410–7.

    Google Scholar 

  22. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta-analysis. Int J Geriatr Psychiatry. 2007;22(7):613–26.

    PubMed  Google Scholar 

  23. Williams SA, Kasl SV, Heiat A, Abramson JL, Krumholz HM, Vaccarino V. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med. 2002;64(1):6–12.

    PubMed  Google Scholar 

  24. Filik R, Sipos A, Kehoe PG, et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand. 2006;113(4):298–305.

    CAS  PubMed  Google Scholar 

  25. Sundquist K, Li X. Alcohol abuse partly mediates the association between coronary heart disease and affective or psychotic disorders: a follow-up study in Sweden. Acta Psychiatr Scand. 2006;113(4):283–9.

    CAS  PubMed  Google Scholar 

  26. McDermott S, Moran R, Platt T, Isaac T, Wood H, Dasari S. Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Community Ment Health J. 2005;41(6):747–55.

    PubMed  Google Scholar 

  27. Suvisaari J, Perälä J, Saarni SI, Kattainen A, Lönnqvist J, Reunanen A. Coronary heart disease and cardiac conduction abnormalities in persons with psychotic disorders in a general population. Psychiatry Res. 2010;175(1–2):126–32.

    PubMed  Google Scholar 

  28. Goff DC, Sullivan LM, McEvoy JP, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80(1):45–53.

    PubMed  Google Scholar 

  29. de Hert M, Schreurs V, Vancampfort D, Van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry. 2009;8(1):15–22.

    Google Scholar 

  30. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–23.

    CAS  PubMed  Google Scholar 

  31. Masopust J, Malý R, Andrýs C, Vališ M, Bažant J, Ladislav Hosák L. Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC Psychiatry. 2011;11:2. This study deduced that psychosis per se, regardless of the intake of antipsychotics increases the risk of developing CVD.

    PubMed Central  PubMed  Google Scholar 

  32. Sherwood A, Hinderliter AL, Watkins LL, Waugh RA, Blumenthal JA. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol. 2005;46(4):656–9.

    PubMed  Google Scholar 

  33. Israel AK, Seeck A, Boettger MK, et al. Peripheral endothelial dysfunction in patients suffering from acute schizophrenia: a potential marker for cardiovascular morbidity? Schizophr Res. 2011;128(1–3):44–50.

    PubMed  Google Scholar 

  34. Nemeroff CB, Musselman DL. Are platelets the link between depression and ischemic heart disease? Am Heart J. 2000;140(4 Suppl):57–62.

    CAS  PubMed  Google Scholar 

  35. Geiser F, Meier C, Wegener I, et al. Association between anxiety and factors of coagulation and fibrinolysis. Psychother Psychosom. 2008;77(6):377–83.

    PubMed  Google Scholar 

  36. Otte C, Marmar CR, Pipkin SS, Moos R, Browner WS, Whooley MA. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study. Biol Psychiatry. 2004;56(4):241–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  37. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol. 2008;4:189–216.

    PubMed  Google Scholar 

  38. Joynt KE, Whellan DJ, O’connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail. 2004;10(3):258–71.

    PubMed  Google Scholar 

  39. Nair N, Farmer C, Gongora E, Dehmer GJ. Commonality between depression and heart failure. Am J Cardiol. 2012;109(5):768–72.

    PubMed  Google Scholar 

  40. Drago S, Bergerone S, Anselmino M, et al. Depression in patients with acute myocardial infarction: influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study. Int J Cardiol. 2007;115(1):46–51.

    PubMed  Google Scholar 

  41. Martens EJ, Nyklícek I, Szabó BM, Kupper N. Depression and anxiety as predictors of heart rate variability after myocardial infarction. Psychol Med. 2008;38(3):375–83.

    CAS  PubMed  Google Scholar 

  42. Bär KJ, Boettger MK, Koschke M, et al. Non-linear complexity measures of heart rate variability in acute schizophrenia. Clin Neurophysiol. 2007;118(9):2009–15.

    PubMed  Google Scholar 

  43. Miu AC, Heilman RM, Miclea M. Reduced heart rate variability and vagal tone in anxiety: trait versus state, and the effects of autogenic training. Auton Neurosci. 2009;145(1–2):99–103.

    PubMed  Google Scholar 

  44. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients. J Psychosom Res. 2009;66(3):189–94.

    PubMed  Google Scholar 

  45. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91(11):988–98.

    CAS  PubMed  Google Scholar 

  46. Jiang W, Glassman A, Krishnan R, O’Connor CM, Califf RM. Depression and ischemic heart disease: what have we learned so far and what must we do in the future? Am Heart J. 2005;150(1):54–78.

    PubMed  Google Scholar 

  47. Paraskevaidis I, Palios J, Parissis J, Filippatos G, Anastasiou-Nana M. Treating depression in coronary artery disease and chronic heart failure: what’s new in using selective serotonin re-uptake inhibitors? Cardiovasc Hematol Agents Med Chem. 2012;10(2):109–15. SSRIs have properties other than their antidepressant action that may add to their beneficial effect in depressed patients with CVD, aiming towards better cardiac prognosis.

    PubMed  Google Scholar 

  48. Pizzi C, Rutjes AW, Costa GM, Fontana F, Mezzetti A, Manzoli L. Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol. 2011;107(7):972–9.

    CAS  PubMed  Google Scholar 

  49. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(Suppl):S8–S21.

    PubMed  Google Scholar 

  50. Smith KJ, Béland M, Clyde M, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74(2):89–99.

    PubMed  Google Scholar 

  51. Petrak F, Hardt J, Wittchen HU, et al. Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. Diabetes Metab Res Rev. 2003;19(3):216–22.

    PubMed  Google Scholar 

  52. Kruse J, Schmitz N, Thefeld W. On the association between diabetes and mental disorders in a community sample: results from the German National Health Interview and Examination Survey. Diabetes Care. 2003;26(6):1841–6.

    PubMed  Google Scholar 

  53. Anderson RJ, Grigsby AB, Freedland KE, et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32(3):235–47.

    PubMed  Google Scholar 

  54. Ogawa M, Miyamoto Y, Kawakami N. Factors associated with glycemic control and diabetes self-care among outpatients with schizophrenia and type 2 diabetes. Arch Psychiatr Nurs. 2011;25(1):63–73.

    PubMed  Google Scholar 

  55. Demet MM, Ozmen B, Deveci A, Boyvada S, Adigüzel H, Aydemir O. Depression and anxiety in hyperthyroidism. Arch Med Res. 2002;33(6):552–6.

    PubMed  Google Scholar 

  56. Zainal N, Yaacob S, Kaur A, Pendek R. Prevalence of depression and anxiety disorders among thyroid disorder patients in a teaching hospital in Malaysia. Eur Psychiatry. 2010;25 Suppl 1:527.

    Google Scholar 

  57. Engum A, Bjøro T, Mykletun A, Dahl AA. An association between depression, anxiety and thyroid function—a clinical fact or an artefact? Acta Psychiatr Scand. 2002;106(1):27–34.

    CAS  PubMed  Google Scholar 

  58. Engum A, Bjøro T, Mykletun A, Dahl AA. Thyroid autoimmunity, depression and anxiety; are there any connections? An epidemiological study of a large population. J Psychosom Res. 2005;59(5):263–8.

    PubMed  Google Scholar 

  59. Patten SB, Williams JV, Esposito E, Beck CA. Self-reported thyroid disease and mental disorder prevalence in the general population. Gen Hosp Psychiatry. 2006;28(6):503–8.

    PubMed  Google Scholar 

  60. Krishna VN, Thunga R, Unnikrishnan B, et al. Association between bipolar affective disorder and thyroid dysfunction. Asian J Psychiatr. 2013;6(1):42–5.

    PubMed  Google Scholar 

  61. Kupka RW, Nolen WA, Post RM, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry. 2002;51(4):305–11.

    CAS  PubMed  Google Scholar 

  62. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49(5):837–45.

    CAS  PubMed  Google Scholar 

  63. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383–90.

    PubMed Central  PubMed  Google Scholar 

  64. Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Ostenson CG. Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med. 2008;25(7):834–42.

    PubMed  Google Scholar 

  65. Verma SK, Subramaniam M, Liew A, Poon LY. Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry. 2009;70(7):997–1000.

    PubMed  Google Scholar 

  66. Rustad JK, Musselman DL, Nemeroff CB. The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology. 2011;36(9):1276–86.

    PubMed  Google Scholar 

  67. Chiodini I, Adda G, Scillitani A, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care. 2007;30(1):83–8.

    CAS  PubMed  Google Scholar 

  68. Stuart MJ, Baune BT. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev. 2012;36(1):658–76.

    CAS  PubMed  Google Scholar 

  69. O’Donovan A, Slavich GM, Epel ES, Neylan TC. Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev. 2013;37(1):96–108.

    PubMed  Google Scholar 

  70. Steiner J, Bernstein HG, Schiltz K, et al. Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:287–94.

    CAS  PubMed  Google Scholar 

  71. Wu EL, Chien IC, Lin CH, Chou YJ, Chou P. Increased risk of hypothyroidism and hyperthyroidism in patients with major depressive disorder: a population-based study. J Psychosom Res. 2013;74(3):233–7.

    PubMed  Google Scholar 

  72. Van Melick EJ, Wilting I, Meinders AE, Egberts TC. Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: lithium and nonlithium patients. Am J Geriatr Psychiatry. 2010;18(5):395–403.

    PubMed  Google Scholar 

  73. Chakrabarti S. Thyroid functions and bipolar affective disorder. J Thyroid Res. 2011;2011:306367.

    PubMed Central  PubMed  Google Scholar 

  74. van der Feltz-Cornelis CM, Nuyen J, Stoop C, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2010;32(4):380–95.

    PubMed  Google Scholar 

  75. Gitlin M, Altshuler LL, Frye MA, et al. Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. J Psychiatry Neurosci. 2004;29(5):383–6.

    PubMed Central  PubMed  Google Scholar 

  76. Eker SS, Akkaya C, Sarandol A, Cangur S, Sarandol E, Kirli S. Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(4):955–61.

    CAS  PubMed  Google Scholar 

  77. McIntyre RS, Leiter L, Yale JF, et al. Schizophrenia, glycemia and antipsychotic medications: an expert consensus review. Can J Diabetes. 2005;29(2):113–21.

    Google Scholar 

  78. Bou Khalil R, Richa S. Thyroid adverse effects of psychotropic drugs: a review. Clin Neuropharmacol. 2011;34(6):248–55.

    PubMed  Google Scholar 

  79. Feret BM, Caley CF. Possible hypothyroidism associated with quetiapine. Ann Pharmacother. 2000;34(4):483–6.

    CAS  PubMed  Google Scholar 

  80. Church CO, Callen EC. Myxedema coma associated with combination aripiprazole and sertraline therapy. Ann Pharmacother. 2009;43(12):2113–6.

    PubMed  Google Scholar 

  81. Okasha A. Focus on psychiatry in Egypt. Br J Psychiatry. 2004;185:266–72.

    CAS  PubMed  Google Scholar 

  82. El-Islam MF. Arab culture and mental health care. Transcult Psychiatry. 2008;45(4):671–82.

    Google Scholar 

  83. Radwan A, supervised by Okasha A, Abdel-Aziz M, Ghanem M, Okasha T, Abdel-Samei A. Psychiatric morbidity in a sample of Egyptian patients with selected cardiovascular and endocrinal diseases at Ain-Shams University Hospital. [MD thesis]. Cairo: Ain Shams University; 2013.

  84. Sharraf YA, Bedir RA, Ibrahim MM. Prevalence and correlates of hypertensive complications in Egyptians. Med J Cairo Univ. 2003;71:747–53.

    Google Scholar 

  85. Almahmeed W, Arnaout MS, Chettaou R, et al. Coronary artery disease in Africa and the Middle East. Ther Clin Risk Manag. 2012;8:65–72.

    PubMed Central  PubMed  Google Scholar 

  86. Ellabany E, Abel-Nasser M. Community based survey study on non-communicable diseases and their risk factors, Egypt, 2005–2006. World Health Organization. Report number: STEPS_Report_Egypt_2005-06.

  87. El-Mougi FA, Abd-El-Ghaffar S, Fayek NA, Mohammed MS. Urinary iodine and other iodine deficiency indicators in a sample of school-age children in Egypt. East Mediterr Health J. 2004;10(6):863–70.

    CAS  PubMed  Google Scholar 

  88. Abd El-Hay MA, Al-Sawy H, AbdAlmageed R. Prevalence and risk factors of post-myocardial infarction major depressive disorder. Egypt J Psychiatry. 2005;24:103–9.

    Google Scholar 

  89. Bunevicius A, Staniute M, Brozaitiene J, Pop VJ, Neverauskas J, Bunevicius R. Screening for anxiety disorders in patients with coronary artery disease. Health Qual Life Outcomes. 2013;11:37.

    PubMed Central  PubMed  Google Scholar 

  90. Parker G, Hyett M, Walsh W, Owen C, Brotchie H, Hadzi-Pavlovic D. Specificity of depression following an acute coronary syndrome to an adverse outcome extends over five years. Psychiatry Res. 2011;185(3):347–52.

    PubMed  Google Scholar 

  91. Holzapfel N, Zugck C, Müller-Tasch T, et al. Routine screening for depression and quality of life in outpatients with congestive heart failure. Psychosomatics. 2007;48(2):112–6.

    PubMed  Google Scholar 

  92. Yu DS, Thompson DR, Yu CM, Oldridge NB. Assessing HRQL among Chinese patients with coronary heart disease: angina, myocardial infarction and heart failure. Int J Cardiol. 2009;131(3):384–94.

    PubMed  Google Scholar 

  93. Adewuya AO, Ola BA, Ajayi OE, Oyedeji AO, Balogun MO, Mosaku SK. Prevalence and correlates of major depressive disorder in Nigerian outpatients with heart failure. Psychosomatics. 2006;47(6):479–85.

    PubMed  Google Scholar 

  94. Bouwman V, Adriaanse MC, van’t Riet E, et al. Depression, anxiety and glucose metabolism in the general Dutch population: the new Hoorn study. PLoS ONE. 2010;5(4):e9971.

    PubMed Central  PubMed  Google Scholar 

  95. Lin EH, Heckbert SR, Rutter CM, et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009;7(5):414–21.

    PubMed Central  PubMed  Google Scholar 

  96. Khuwaja AK, Lalani S, Dhanani R, Azam IS, Rafique G, White F. Anxiety and depression among outpatients with type 2 diabetes: a multi-centre study of prevalence and associated factors. Diabetol Metab Syndr. 2010;2:72.

    PubMed Central  PubMed  Google Scholar 

  97. Naqvi TZ, Rafique AM, Andreas V, Rahban M, Mirocha J, Naqvi SS. Predictors of depressive symptoms post-acute coronary syndrome. Gend Med. 2007;4(4):339–51.

    PubMed  Google Scholar 

  98. Goodwin RD, Kroenke K, Hoven CW, Spitzer RL. Major depression, physical illness, and suicidal ideation in primary care. Psychosom Med. 2003;65(4):501–5.

    PubMed  Google Scholar 

  99. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26(2):153–61.

    CAS  PubMed  Google Scholar 

  100. Tovilla-Zárate C, Juárez-Rojop I, Peralta Jimenez Y, et al. Prevalence of anxiety and depression among outpatients with type 2 diabetes in the Mexican population. PLoS One. 2012;7(5):e36887.

    PubMed Central  PubMed  Google Scholar 

  101. Bener A, Al-Hamaq A, Dafeeah E. High prevalence of depression, anxiety and stress symptoms among diabetes mellitus patients. Open Psychiatry J. 2011;5:5–12.

    Google Scholar 

  102. Chung ML, Lennie TA, Dekker RL, Wu JR, Moser DK. Depressive symptoms and poor social support have a synergistic effect on event-free survival in patients with heart failure. Heart Lung. 2011;40(6):492–501.

    PubMed Central  PubMed  Google Scholar 

  103. Roger D, Pies R. General medical drugs associated with depression. Psychiatry. 2008;5:28–41.

    Google Scholar 

  104. Celano CM, Freudenreich O, Fernandez-Robles C, Stern TA, Caro MA, Huffman JC. Depressogenic effects of medications: a review. Dialogues Clin Neurosci. 2011;13(1):109–25. This paper indicates that angiotensin-converting enzyme inhibitors do not exacerbate depression in patients with CVD. Moreover, they might have an antidepressant effect.

    PubMed Central  PubMed  Google Scholar 

  105. Strine TW, Mokdad AH, Balluz LS, et al. Depression and anxiety in the United States: findings from the 2006 behavioral risk factor surveillance system. Psychiatr Serv. 2008;59(12):1383–90.

    PubMed  Google Scholar 

  106. Dickens CM, McGowan L, Percival C, et al. Contribution of depression and anxiety to impaired health-related quality of life following first myocardial infarction. Br J Psychiatry. 2006;189:367–72.

    CAS  PubMed  Google Scholar 

  107. Chung ML, Moser DK, Lennie TA, Rayens MK. The effects of depressive symptoms and anxiety on quality of life in patients with heart failure and their spouses: testing dyadic dynamics using Actor-Partner Interdependence Model. J Psychosom Res. 2009;67(1):29–35.

    PubMed Central  PubMed  Google Scholar 

  108. Eren I, Erdi O, Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depress Anxiety. 2008;25(2):98–106.

    PubMed  Google Scholar 

  109. Arne M, Janson C, Janson S, et al. Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus. Scand J Prim Health Care. 2009;27(3):141–7.

    PubMed Central  PubMed  Google Scholar 

  110. Sprangers MA, de Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000;53(9):895–907.

    CAS  PubMed  Google Scholar 

  111. Alonso J, Ferrer M, Gandek B, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13(2):283–98.

    PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Tarek Okasha and Ash-Shayma Radwan declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Institute of Psychiatry, Ain Shams University, Cairo, Egypt

    Tarek Okasha & Ash-Shayma Radwan

Authors
  1. Tarek Okasha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ash-Shayma Radwan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tarek Okasha.

Additional information

This article is part of the Topical Collection on Complex Medical-Psychiatric Issues

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okasha, T., Radwan, AS. The Bidirectional Relation Between Psychiatric Disorders With Selected Cardiovascular and Endocrinal Diseases: An Egyptian Perspective. Curr Psychiatry Rep 17, 528 (2015). https://doi.org/10.1007/s11920-014-0528-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11920-014-0528-y

Keywords

Search

Navigation